We are a private investment company. We fund the final clinical trials late-stage medical devices need to earn their insurance reimbursement codes.
We fund the final clinical trials a device needs to earn its insurance reimbursement codes, in return for a convertible note and a board seat. We favor devices and tools, not drugs or procedures: non-surgical, non-injectable, non-consumable and non-reactive, making an immediate, measurable difference for the patient. Too many proven products are helped early by grants and galas, then abandoned inches from full deployment. We fill that gap.
We invest our own capital alongside capital partners we choose, $2M to $5M per opportunity. We back people we trust, running companies on strong fundamentals, values and ethics. A good outcome is one where all parties are better off, financially, physically or psychologically.
Behind this are thirty years of building and operating companies: starting them, running them, turning them around, and structuring deals that would not have closed on their own.
If you invest in late-stage healthcare devices and want to compare diligence, or look at an opportunity alongside us, write to us.